Clinical Prediction Model for Pediatric Lymphadenopathy: Enhancing Diagnostic Precision and Treatment Decision Making

Overview

Journal Pediatr Surg Int

Specialties General Surgery
Pediatrics

Date 2024 Jul 27

PMID 39066804

Authors

Tipsuda Tangsriwong

Thipsumon Tangsiwong

Affiliations

Soon will be listed here.

Abstract

Introduction: Lymph node enlargement is common in children, with 90% of physiologically palpable lymph nodes. This study aimed to develop a predictive model based on clinical characteristics to enhance the diagnosis of pediatric lymphadenopathy and provide insights into biopsy outcomes.

Materials And Methods: A clinical prediction rule was developed using a retrospective, cross-sectional design for patients under 15 years who underwent lymph node biopsy from 2012 to 2022. Multivariable risk regression was used to analyze benign and malignant lesions, presenting results through risk difference and AUROC for each group. Predicted probabilities were applied in a logistic regression equation to classify patients' lymphadenopathy as reactive hyperplasia, benign, or malignant.

Results: Of 188 children, 70 (37.2%) had benign lymphadenopathy beyond reactive hyperplasia, and 27 (14.4%) had malignant lymphadenopathy. The predictive model included 12 characteristics such as size, location, duration, associated symptoms, and lymph node examination. Predictive accuracy was 92.2% for benign cases (AUROC = 0.92; 95% CI 0.87-0.96) and 98.6% for malignancy (AUROC = 0.98; 95% CI 0.94-0.99). Overall accuracy for predicting both benign and malignant tumors was 68.3%.

Conclusion: The model demonstrated reasonably accurate predictions for the clinical characteristics of pediatric lymphadenopathy. It tended to overestimate malignancy but did not miss diagnoses, aiding in reducing unnecessary lymph node biopsies in benign cases.

References

Alves Rosa J, Calle-Toro J, Kidd M, Andronikou S . Normal head and neck lymph nodes in the paediatric population. Clin Radiol. 2021; 76(4):315.e1-315.e7. DOI: 10.1016/j.crad.2020.12.020. View

Farndon S, Behjati S, Jonas N, Messahel B . How to use… lymph node biopsy in paediatrics. Arch Dis Child Educ Pract Ed. 2017; 102(5):244-248. DOI: 10.1136/archdischild-2015-309634. View

Grant C, Aldrink J, Lautz T, Tracy E, Rhee D, Baertschiger R . Lymphadenopathy in children: A streamlined approach for the surgeon - A report from the APSA Cancer Committee. J Pediatr Surg. 2020; 56(2):274-281. DOI: 10.1016/j.jpedsurg.2020.09.058. View

Locke R, Comfort R, Kubba H . When does an enlarged cervical lymph node in a child need excision? A systematic review. Int J Pediatr Otorhinolaryngol. 2014; 78(3):393-401. DOI: 10.1016/j.ijporl.2013.12.011. View

Nolder A . Paediatric cervical lymphadenopathy: when to biopsy?. Curr Opin Otolaryngol Head Neck Surg. 2013; 21(6):567-70. DOI: 10.1097/MOO.0000000000000003. View

Sen H, Ocak S, Yilmazbas P . Children with cervical lymphadenopathy: reactive or not?. Turk J Pediatr. 2021; 63(3):363-371. DOI: 10.24953/turkjped.2021.03.003. View

Celenk F, Baysal E, Aytac I, Durucu C, Sari I, Mumbuc S . Incidence and predictors of malignancy in children with persistent cervical lymphadenopathy. Int J Pediatr Otorhinolaryngol. 2013; 77(12):2004-7. DOI: 10.1016/j.ijporl.2013.09.022. View

Berce V, Rataj N, Doric M, Zorko A, Kolaric T . Association between the Clinical, Laboratory and Ultrasound Characteristics and the Etiology of Peripheral Lymphadenopathy in Children. Children (Basel). 2023; 10(10). PMC: 10604910. DOI: 10.3390/children10101589. View

Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A . Peripheral lymphadenopathy: approach and diagnostic tools. Iran J Med Sci. 2014; 39(2 Suppl):158-70. PMC: 3993046. View

10.

Slap G, Connor J, Wigton R, Schwartz J . Validation of a model to identify young patients for lymph node biopsy. JAMA. 1986; 255(20):2768-73. View

11.

Niedzielska G, Kotowski M, Niedzielski A, Dybiec E, Wieczorek P . Cervical lymphadenopathy in children--incidence and diagnostic management. Int J Pediatr Otorhinolaryngol. 2006; 71(1):51-6. DOI: 10.1016/j.ijporl.2006.08.024. View

12.

Seth V, Kabra S, Jain Y, Semwal O, Mukhopadhyaya S, Jensen R . Tubercular lymphadenitis: clinical manifestations. Indian J Pediatr. 1995; 62(5):565-70. DOI: 10.1007/BF02761878. View

13.

Wang J, Pei G, Yan J, Zhao Q, Li Z, Cao Y . Unexplained cervical lymphadenopathy in children: predictive factors for malignancy. J Pediatr Surg. 2010; 45(4):784-8. DOI: 10.1016/j.jpedsurg.2009.08.018. View

14.

Soldes O, Younger J, Hirschl R . Predictors of malignancy in childhood peripheral lymphadenopathy. J Pediatr Surg. 1999; 34(10):1447-52. DOI: 10.1016/s0022-3468(99)90101-x. View

15.

Bozlak S, Varkal M, Yildiz I, Toprak S, Karaman S, Erol O . Cervical lymphadenopathies in children: A prospective clinical cohort study. Int J Pediatr Otorhinolaryngol. 2016; 82:81-7. DOI: 10.1016/j.ijporl.2016.01.002. View